SCSoyeon Chang

Soyeon Chang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Soyeon Chang has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Exploration of Novel Biomarkers Through a Precision Medicine Approach Using Multi‐Omics and Brain Organoids in Patients With Atypical Depression and Psychotic Symptoms

    by Insook Ahn, Soyeon Chang, Jiyoung Lee, Seok‐Ho Choi, Jinju Han, Yangsik Kim

    Major depressive disorder (MDD) with atypical features accompanied by psychotic symptoms represents a severe and under‐researched subtype of depression and severe mental illness, characterized by significant personal and social impact. This study aims to explore novel biomarkers through a precision medicine approach by combining clinical data, white blood cell (WBC) single‐cell RNA sequencing (scRNA‐seq), plasma proteomics, and brain organoid models to uncover immunological and neurological alterations in patients with this condition. Patients exhibited elevated stress, anxiety, depression, and increased WBC counts, although the difference in WBC count is not significant after adjusting for age. Plasma proteomic profiling identified an upregulation of proteins implicated in synaptic formation, including Doublecortin‐Like Kinase 3 (DCLK3) and Calcyon (CALY), as well as immune‐related proteins such as Complement Component 5 (C5). WBC scRNA‐seq revealed significant neutrophil and monocyte transcriptomic alterations, suggesting increased inflammation and immune dysregulation. Patient‐derived brain organoids display reduced growth and distinct gene expression patterns compared to controls, particularly under dexamethasone‐induced stress conditions. Combining WBC scRNA‐seq, plasma proteomics, and brain organoid models offers a novel framework for understanding the pathophysiology of psychiatric disorders, which is one of the most complex disorders.


  • Open Access

    Factors Affecting Continuation of Aripiprazole Long-acting Injection in the Real World

    by Soyeon Chang, Seri Maeng, Yangsik Kim, Jae-Nam Bae, Jeong-Seop Lee, Won-Hyoung Kim

    Soyeon Chang, Seri Maeng, Yangsik Kim, Jae-Nam Bae, Jeong-Seop Lee, Won-Hyoung Kim. Clin Psychopharmacol Neurosci -0001;0:669-. https://doi.org/10.9758/cpn.24.1232


  • Open Access

    Clinical Utility of Impact of Event Scale–Revised for Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition Posttraumatic Stress Disorder

    by Soyeon Chang, Won-Hyoung Kim, Young-Eun Jung, Daeyoung Roh, Daeho Kim, Jeong-Ho Chae, Joo Eon Park

    Objective The Impact of Event Scale–Revised (IES-R) is a widely used self-report for assessing posttraumatic stress disorder (PTSD), originally aligned with Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV diagnostic criteria. This study aimed to evaluate the applicability of the IES-R under the DSM-5 guidelines and establish a cutoff point for DSM-5 PTSD diagnosis.Methods A total of 238 participants recruited from multiple psychiatric centers, including 67 patients with PTSD, 72 patients with psychiatric controls, and 99 healthy controls, were included in the study. All participants completed the Korean version of the Structured Clinical Interview for the DSM-5 research version to confirm the presence of PTSD, the Korean version of PTSD Checklist for DSM-5 (PCL-5), the Beck Depression Inventory-II, the Beck Anxiety Inventory, and the Spielberger State Trait Anxiety Inventory.Results The IES-R demonstrated good internal consistency and a high correlation with the PCL-5. Through factor analysis, 5 distinct dimensions emerged within the IES-R: sleep disturbance, intrusion, hyperarousal, avoidance, and numbness-dissociation. A proposed cutoff score of 25 on the IES-R was suggested for identifying patients with PTSD.Conclusion These findings underscore the scale’s concurrent validity with the DSM-5 PTSD criteria and its effectiveness as a screening tool. Implementing a cutoff score of 25 on the IES-R can enhance its utility in identifying DSM-5 PTSD cases.